26 laws and 25 links: citations, amendments, and UK copies of EU law. Bigger circles are relied on more.
| Law | Links on map | Importance |
|---|---|---|
| EUTFEU | 1 | 13.88 |
| EUTEU | 1 | 3.73 |
| EURegulation (EU) 2017/1001 | 1 | 0.84 |
| EUDirective 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use | 1 | 0.25 |
| EUDirective (EU) 2015/2436 of the European Parliament and of the Council of 16 December 2015 to approximate the laws of the Member States relating to trade marks (recast) (Text with EEA relevance) | 1 | 0.20 |
| EUCommission Delegated Regulation (EU) 2016/161 of 2 October 2015 supplementing Directive 2001/83/EC of the European Parliament and of the Council by laying down detailed rules for the safety features appearing on the packaging of medicinal products for human use (Text with EEA relevance) | 1 | 0.20 |
| EUCouncil Regulation (EC) No 207/2009 of 26 February 2009 on the Community trade mark (codified version) (Text with EEA relevance) | 1 | 0.19 |
| EUDirective 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products Text with EEA relevance | 1 | 0.17 |
| EUDirective 2008/95/EC of the European Parliament and of the Council of 22 October 2008 to approximate the laws of the Member States relating to trade marks (Codified version) (Text with EEA relevance) | 1 | 0.17 |
| EUBristol-Myers Squibb v Paranova A/S and C. H. Boehringer Sohn, Boehringer Ingelheim KG and Boehringer Ingelheim A/S v Paranova A/S and Bayer Aktiengesellschaft and Bayer Danmark A/S v Paranova A/S (C-427/93, C-429/93, C-436/93) | 1 | 0.16 |
| EUSchweppes SA v Red Paralela SL and Red Paralela BCN SL (C-291/16) | 1 | 0.16 |
| EUBoehringer Ingelheim KG and Others v Swingward Ltd and Dowelhurst Ltd (C-348/04) | 1 | 0.16 |
| EUMitsubishi Shoji Kaisha Ltd and Mitsubishi Caterpillar Forklift Europe BV v Duma Forklifts NV and G.S. International BVBA (C-129/17) | 1 | 0.16 |
| EUBoehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd and Eli Lilly and Co. v Swingward Ltd and Dowelhurst Ltd (C-143/00) | 1 | 0.16 |
| EUJunek Europ-Vertrieb GmbH v Lohmann & Rauscher International GmbH & Co. KG (C-642/16) | 1 | 0.16 |
| EUPortakabin Ltd and Portakabin BV v Primakabin BV (C-558/08) | 1 | 0.16 |
| EUFerring Lægemidler A/S, acting on behalf of Ferring BV v Orifarm A/S (C-297/15) | 1 | 0.16 |
| EUOrifarm A/S and Others and Paranova Danmark A/S and Paranova Pack A/S v Merck Sharp & Dohme Corp. and Merck Sharp & Dohme BV and Merck Sharp & Dohme (C-400/09, C-207/10) | 1 | 0.15 |
| EUGintec International Import-Export GmbH v Verband Sozialer Wettbewerb eV (C-374/05) | 1 | 0.15 |
| EUFirst Council Directive 89/104/EEC of 21 December 1988 to approximate the laws of the Member States relating to trade marks | 1 | 0.15 |
| EURegulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance) | 1 | 0.15 |
| EUratiopharm GmbH v Novartis Consumer Health GmbH (C-786/18) | 1 | 0.15 |
| EUThe Wellcome Foundation Ltd v Paranova Pharmazeutika Handels GmbH (C-276/05) | 1 | 0.15 |
| EUC-224/20 Merck Sharp & Dohme and Others | 25 | 0.15 |
| EUDirective 2012/26/EU of the European Parliament and of the Council of 25 October 2012 amending Directive 2001/83/EC as regards pharmacovigilance Text with EEA relevance | 1 | 0.00 |
| EUCouncil Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products | 1 | 0.00 |